Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 124,267 | $0 | 498,901 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 302 | $194.47 | 498,901 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 8,961 | $213.32 | 498,901 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 296 | $159.03 | 498,901 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 115,622 | $0 | 637,624 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 6,802 | $194.47 | 637,624 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 1,796 | $213.32 | 637,624 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 296 | $159.03 | 637,624 (Direct) | View |
| 2025-09-09 Gift | 2025-09-11 5:12 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 148,096 | $0 | 9,984,887 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-09 5:31 pm | N/A 2032-06-21 | BeOne Medicines Ltd. | ONC | Sanders Corazon (Corsee) D. Director | 34,645 | $0 | 57,226 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-09 5:31 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Sanders Corazon (Corsee) D. Director | 2,665 | $155.68 | 57,226 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:40 pm | N/A 2030-06-16 | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 1,167,322 | $0 | 2,622,329 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 57,841 | $155.68 | 2,622,329 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 22,773 | $174.43 | 2,622,329 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-15 4:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 9,180 | $159.03 | 2,622,329 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:38 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 106,990 | $0 | 518,752 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 4,381 | $194.47 | 518,752 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 3,849 | $159.03 | 518,752 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:51 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Ball Titus B. Principal Accounting Officer | 29,601 | $0 | 0 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:49 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 135,122 | $0 | 372,164 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:45 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Rosenberg Aaron Chief Financial Officer | 183,547 | $0 | 350,675 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:44 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Wang Lai Global Head of R&D | 248,924 | $0 | 1,952,834 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:42 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 355,615 | $0 | 1,522,906 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-12 5:39 pm | N/A 2025-07-19 | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 5,164,016 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-12 5:39 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 5,164,016 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:39 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 284,492 | $0 | 5,164,016 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 5:38 pm | N/A 2035-06-09 | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 533,429 | $0 | 54,685,531 (Direct) | View |
| 2025-06-10 Other | 2025-06-12 4:19 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Yi Qingqing Director | 29,614 | $0 | 56,940 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Yi Qingqing Director | 33,735 | $0 | 79,690 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:47 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Sharp Shalini Director | 33,735 | $0 | 41,886 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:46 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director | 33,735 | $0 | 50,076 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:44 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 33,735 | $0 | 79,690 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:44 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 33,735 | $0 | 79,690 (Direct) | View |
| 2025-05-21 Option Award | 2025-05-22 7:42 pm | N/A 2035-05-20 | BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director | 33,735 | $0 | 79,976 (Direct) | View |